G. Pillai

发表

Sarcosine based indandione hGlyT1 inhibitors.

S. Fletcher, I. Huscroft, P. Raubo, 2006, Bioorganic & medicinal chemistry letters.

Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.

A. Howell, D. Anderson, A. Mcmahon, 1988, BMJ.

3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of alpha5-containing GABAA receptors.

J. Atack, A. Macleod, A. Macaulay, 2004, Bioorganic & medicinal chemistry letters.

Multiple structural features of steroids mediate subtype-selective effects on human α4β3δ GABAA receptors

P. Hunt, Alison J. Smith, P. B. Simpson, 2004 .

Pharmacology of recombinant human GABAA receptor subtypes measured using a novel pH-based high-throughput functional efficacy assay

K. Maubach, G. Seabrook, P. B. Simpson, 2000, Journal of Neuroscience Methods.

Evaluation of the Effects of Varying Solute Content on the Efficacy of Oral Rehydration Solutions in a Rat Model of Secretory Diarrhoea

M. Brueton, B. Sandhu, G. Pillai, 1994, Journal of pediatric gastroenterology and nutrition.

Human D2 and D4 dopamine receptors couple through β γ G-protein subunits to inwardly rectifying K+ channels (GIRK1) in a Xenopus oocyte expression system: selective antagonism by L-741,626 and L-745,870 respectively

G. Milligan, G. Mcallister, G. Seabrook, 1998, Neuropharmacology.

A New Pyridazine Series of GABAA α5 Ligands

U. Gerhard, J. Atack, D. O'connor, 2005 .

Compounds Exhibiting Selective Efficacy for Different β Subunits of Human Recombinant γ-Aminobutyric AcidA Receptors

Alison J. Smith, P. B. Simpson, G. Pillai, 2004, Journal of Pharmacology and Experimental Therapeutics.

Identification of amino acid residues responsible for the α5 subunit binding selectivity of L‐655,708, a benzodiazepine binding site ligand at the GABAA receptor

P. Whiting, K. Maubach, G. Seabrook, 2001 .

Identification of amino acid residues responsible for the alpha5 subunit binding selectivity of L-655,708, a benzodiazepine binding site ligand at the GABA(A) receptor.

P. Whiting, K. Maubach, G. Seabrook, 2001, Journal of neurochemistry.

α4β3δ GABAAReceptors Characterized by Fluorescence Resonance Energy Transfer-derived Measurements of Membrane Potential*

C. Adkins, R. Mckernan, P. Whiting, 2001, The Journal of Biological Chemistry.

An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition

N Collinson, B. Everitt, J. Atack, 2006, Journal of Pharmacology and Experimental Therapeutics.

Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1.

A. Pike, H. Burns, T. Hamill, 2010, ACS medicinal chemistry letters.

3,4‐Dihydronaphthalen‐1(2H)‐ones: Novel Ligands for the Benzodiazepine Site of α5‐Containing GABAA Receptors.

J. Atack, A. Macleod, A. Macaulay, 2004 .

alpha4beta3delta GABA(A) receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential.

C. Adkins, R. Mckernan, P. Whiting, 2001, The Journal of biological chemistry.